Revive Therapeutics Ltd (RVVTF)

[hotmeat]

Could not disagree more, re, that it's "too late" for Buc.

Our drug is a totally different animal than vaccines, which in case you haven't noticed, 50%+ of the World still rejects.

Buc IMO will serve the larger section of the population that does not need, nor want these vaccines.

If the Trial proves to be effective Buc could be used to treat or as a therapeutic for persons afflicted with Covid or similar type diseases.

According to the the official stats, 113M have been infected and 2.5M have died from Covid, allegedly,....this represents 1.5% and 0.03% respectively.

It's very obvious that vaccines are being ""pushed"" solely for the purpose of enriching Big Pharma....95%+ of the World population DOES NOT NEED IT!!!!

Here is where Buc, IF EFFECTIVE, will be able to capitalize IMO.


EDIT: Research costs $$ and IMO this was the primary reason for the delay. Not sure what RVV's options were since other well funded companies are slightly ahead of us and some lagging far behind in terms of research.